Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/29/2000WO2000037066A2 A method for the prophylactic treatment of cataracts
06/29/2000WO2000037065A2 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
06/29/2000WO2000037064A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
06/29/2000WO2000037063A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
06/29/2000WO2000037062A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
06/29/2000WO2000037061A2 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION
06/29/2000WO2000037059A2 Compositions and methods to inactivate n-type calcium channels
06/29/2000WO2000037058A1 Transparent transdermal nicotine delivery devices
06/29/2000WO2000037057A2 Novel formulations comprising lipid-regulating agents
06/29/2000WO2000037055A1 Controlled release formulation of divalproex sodium
06/29/2000WO2000037054A1 A pharmaceutical mixture comprising a profen
06/29/2000WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000WO2000037051A1 Aerosol formulations for buccal and pulmonary application
06/29/2000WO2000037050A1 Water-insoluble drug delivery system
06/29/2000WO2000037047A1 Composition set and kit for use in intraocular surgery
06/29/2000WO2000037040A1 Skin care compositions containing cis-9, trans-11 linoleic acid
06/29/2000WO2000037038A1 Utilization of an extract of a plant of the cecropia genus
06/29/2000WO2000037037A2 Composition for treatment of burns
06/29/2000WO2000037035A1 Deodorizing cosmetic agents
06/29/2000WO2000037027A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000WO2000037026A1 Dihydropyrimidines and uses thereof
06/29/2000WO2000037024A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates
06/29/2000WO2000037022A2 Combination therapy for the treatment of sepsis
06/29/2000WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000WO2000036918A1 Methods and compositions for treatment of cell proliferative disorders
06/29/2000WO2000036915A1 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
06/29/2000WO2000023447B1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties
06/29/2000WO2000016757A8 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
06/29/2000WO2000015237A9 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
06/29/2000WO2000014262A3 Methylation of plasmid vectors
06/29/2000WO2000013687A3 Sustained release ranolazine formulations
06/29/2000WO2000012506A3 Collections of compounds
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000012175A3 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
06/29/2000WO2000011926A3 Method for the preparation of citalopram
06/29/2000WO2000010973A3 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
06/29/2000WO2000010965A3 Quaternary ammonium salts and their use as anti-hiv agents
06/29/2000WO2000010547A3 New use of taxoid derivatives
06/29/2000WO2000009112A3 Heterocyclic esters or amides for vision and memory disorders
06/29/2000WO2000006605A3 Heterominibodies
06/29/2000WO2000004893A3 Imidazoline receptor binding compounds
06/29/2000WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker
06/29/2000WO2000000183A3 Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
06/29/2000WO1999066909A3 Method and compositions for the treatment or amelioration of female sexual dysfunction
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000WO1999063974A3 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
06/29/2000WO1999055854A3 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
06/29/2000DE19913528A1 Treatment of cerebrovascular disease, e.g. due to cerebral ischemia, uses low dosage of the angiotensin converting enzyme inhibitor moexipril
06/29/2000DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases
06/29/2000DE19860543A1 Non-toxic inhibitors of proteases, especially metallo-proteases or collagenase, comprise verongamine or derivatives, useful in cancer treatment
06/29/2000DE19860371A1 Kosmetische oder medizinische Zubereitung für die topische Anwendung Cosmetic or medical composition for topical application
06/29/2000DE19859727A1 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung The use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related organ dysfunctions, age-related diseases for prolonging life
06/29/2000DE19859636A1 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff A controlled release pharmaceutical composition comprising as an active ingredient tilidine mesylate
06/29/2000DE19859045A1 Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung Emulsion of oil in water with a protective effect against peroxidation of human organs, their preparation and use
06/29/2000DE19858812A1 Desodorierende kosmetische Mittel Deodorizing cosmetic products
06/29/2000DE19854310A1 Verwendung von Phosphonoameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen Using Phosphonoameisensäurederivaten for the therapeutic and prophylactic treatment of infections
06/29/2000CA2359603A1 Preventive against respiratory infectious diseases
06/29/2000CA2358492A1 Combination therapy for the treatment of sepsis
06/29/2000CA2357760A1 Process for preparing n6-substituted deaza-adenosine derivatives
06/29/2000CA2357413A1 Sensitizing agents for the treatment of skin lesions
06/29/2000CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000CA2356887A1 Assays for ligands for nuclear receptors
06/29/2000CA2356765A1 Bone resorption inhibitors
06/29/2000CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000CA2356624A1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
06/29/2000CA2356460A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000CA2356289A1 Organophosphorous compounds and use thereof
06/29/2000CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000CA2356244A1 Somatic cells with ablated prp gene and methods of use
06/29/2000CA2356181A1 Triazineone compounds for treating diseases due to sarcocystis, neospora and toxoplasma
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2356134A1 Sulfonyloxazolamines as therapeutic active compounds
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000CA2355848A1 Dihydropyrimidines and uses thereof
06/29/2000CA2355840A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer
06/29/2000CA2355822A1 S-oxide lipid lowering compounds
06/29/2000CA2355820A1 Novel formulations comprising lipid-regulating agents
06/29/2000CA2355704A1 Melatonin derivatives and medicine containing same
06/29/2000CA2355694A1 Novel bicyclic compounds
06/29/2000CA2355469A1 Dibenzo[a,g]quinolizinium derivatives and the salts thereof
06/29/2000CA2355368A1 Cgmp pde 5 inhibitors for inhalation in the treatment of sexual dysfunction
06/29/2000CA2355295A1 Combination of cerivastatin and fibrates
06/29/2000CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
06/29/2000CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000CA2355148A1 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354779A1 Tricyclic farnesyl protein transferase inhibitors
06/29/2000CA2354536A1 Ribavirin-pegylated interferon alfa induction hcv combination therapy
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000CA2354074A1 Method of identifying a psychotropic agent using differential gene expression
06/29/2000CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000CA2353775A1 Compositions and methods for the treatment of tumor
06/29/2000CA2353635A1 Anilide derivative, production and use thereof
06/29/2000CA2352326A1 Combination chemotherapy
1 ... 6291 6292 6293 6294 6295 6296 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 ... 7860